- Home
- LSE vs MDXH Comparison
LSE vs MDXH Comparison
Compare LSE & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSE
- MDXH
- Stock Information
- Founded
- LSE 2007
- MDXH 2003
- Country
- LSE China
- MDXH Belgium
- Employees
- LSE N/A
- MDXH N/A
- Industry
- LSE Metal Fabrications
- MDXH
- Sector
- LSE Industrials
- MDXH
- Exchange
- LSE Nasdaq
- MDXH Nasdaq
- Market Cap
- LSE 84.0M
- MDXH 93.1M
- IPO Year
- LSE 2024
- MDXH 2021
- Fundamental
- Price
- LSE $5.00
- MDXH $2.13
- Analyst Decision
- LSE
- MDXH Strong Buy
- Analyst Count
- LSE 0
- MDXH 2
- Target Price
- LSE N/A
- MDXH $7.00
- AVG Volume (30 Days)
- LSE 655.2K
- MDXH 122.2K
- Earning Date
- LSE 01-01-0001
- MDXH 11-06-2024
- Dividend Yield
- LSE N/A
- MDXH N/A
- EPS Growth
- LSE 174.44
- MDXH N/A
- EPS
- LSE 0.82
- MDXH N/A
- Revenue
- LSE $83,737,603.00
- MDXH $84,708,000.00
- Revenue This Year
- LSE N/A
- MDXH $27.57
- Revenue Next Year
- LSE N/A
- MDXH $20.09
- P/E Ratio
- LSE $6.07
- MDXH N/A
- Revenue Growth
- LSE 167.90
- MDXH 33.01
- 52 Week Low
- LSE $3.76
- MDXH $1.55
- 52 Week High
- LSE $5.88
- MDXH $4.64
- Technical
- Relative Strength Index (RSI)
- LSE N/A
- MDXH 49.73
- Support Level
- LSE N/A
- MDXH $2.00
- Resistance Level
- LSE N/A
- MDXH $2.52
- Average True Range (ATR)
- LSE 0.00
- MDXH 0.17
- MACD
- LSE 0.00
- MDXH -0.01
- Stochastic Oscillator
- LSE 0.00
- MDXH 35.00
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.